Health Ministers Accelerate Goals to Diagnose and Treat Drug-Resistant TB

After last week’s World Health Organization (WHO)-sponsored meeting, health ministers from countries with a high disease burden of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) committed towards accelerated goals for the detection, prevention, and treatment of MDR- and XDR-TB. 

The governments present issued a Call for Action asserting that all countries would take action to meet the following goals:

  • universal access to M/XDR-TB diagnosis and treatment by 2015;
  • removal of financial barriers to TB care;
  • development of a comprehensive M/XDR-TB management and care framework;
  • sufficient staff are trained and deployed;
  • strengthen laboratory systems;
  • collaboration with all partners;
  • development and implementation of airborne infection control policies;
  • sufficient supply of high-quality anti-TB drugs;
  • strengthen mechanisms to ensure availability of TB medicines is regulated;
  • develop the new tools needed to combat M/XDR-TB.

The Call for Action is a major step in coordinating plans for M/XDR-TB prevention, treatment and care and a commitment to achieve universal access to diagnosis and treatment for MDR-TB patients by 2015.

Learn more facts about MDR-TB and XDR-TB after the jump. Continue reading


Bill Gates partners with Chinese government to fight TB


bill-gates-china-tb-partnership1At a global meeting in China, of health ministers from 27 countries affected by the rise of multi-drug resistant (MDR) TB, Bill Gates and the Chinese Minister of Health Chen Zhu announced an innovative partnership to help fight a serious tuberculosis epidemic in China.  The 5 year initiative will be led by the Chinese Ministry of Health and funded by a grant of $33million from the Bill & Melinda Gates Foundation.

Bill Gates, co- chair of the Bill & Melinda Gates Foundation said that the rise of drug-resistant TB worldwide has created a new urgency to combat the disease, while scientific innovation is leading to new technologies. He explained in his speech, the foundation’s choice of China for this partnership:

“China is taking the threat of TB very seriously, and we’re excited to support its efforts.” He added, “Because of its skill, its scale, its TB burden, its love of innovation and its political commitment to public health, China is a perfect laboratory for large-scale testing of new tools and delivery techniques to fight TB.”

“If China leads in the fight against TB – developing new approaches here in China and demonstrating them to the world – we can see a dramatic drop in the number of TB deaths in the next decade.”

According to the Bill & Melinda Gates Foundation, the goal of the partnership was “to improve detection and treatment of the estimated 1.5 million TB cases that occur each year in China, drawing on the latest innovations in TB control.”

The Chinese Minister of Health, Chen said that the new tuberculosis prevention and control program was a continuation of the successful cooperation between the Chinese Ministry of Health and the Gates Foundation that began on the issue of HIV/AIDS. 

Minister Chen added, “It aims to establish an effective TB prevention model through the exploration of new diagnostic tools and methods. This will not only benefit TB prevention and control efforts both in China and throughout the world, but it also sets an excellent example of the partnership between government and private sectors that is widely promoted by the international community, and we hope it will accelerate the progress of reaching the United Nations Millennium Development Goals.”

Funding from the Gates Foundation will help China introduce new TB diagnostic tests, patient monitoring strategies, drug regimens and health delivery approaches that could significantly improve the effectiveness of TB diagnosis and treatment across the country.

The initiative will be implemented in 6 provinces in China. During the first two-and-a-half years, innovative tools and delivery approaches will be pilot-tested to determine their effectiveness and feasibility. Following the completion of the first two-and-a-half years of this partnership, China will determine how to progressively expand the innovations that have been proven to be effective into 20 cities, diagnosing and treating 50,000 TB patients each year.

The new technologies and innovative delivery methods to be piloted include:

Continue reading